Education
About Us
Working with TipRanks
Follow Us
Jennifer Buell Insider Profile
4 Followers
Jennifer Buell, Director at Agenus, holds 67.97K shares in MiNK Therapeutics (Ticker: INKT), holds 19.74K shares in Agenus (Ticker: AGEN), holds ― shares in Protagenic Therapeutics (Ticker: PTIX).
Jennifer Buell has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jennifer Buell holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jennifer Buell
Jennifer Buell's Trading History
Agenus
May 06, 2025
Director
Uninformative Buy
1.81K
$64.94K
MiNK Therapeutics
Jan 06, 2026
CEO
Uninformative Buy
349.99K
$619.85K
Protagenic Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Jennifer Buell's performance on stock
You May Also Like
Jennifer Buell insider profile FAQ
What is the percentage of profitable transactions made by Jennifer Buell?
The percentage of profitable transactions made by Jennifer Buell is ―.
What is the average return per transaction made by Jennifer Buell?
The average return per transaction made by Jennifer Buell is ―.
What stocks does Jennifer Buell hold?
Jennifer Buell holds: AGEN, INKT, PTIX stocks.
What was Jennifer Buell’s latest transaction?
Jennifer Buell latest transaction was an Uninformative Buy of $349.99K.
What was Jennifer Buell's most profitable transaction?
Jennifer Buell’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jennifer Buell's role in Agenus?
Jennifer Buell's role in Agenus is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.